Mechanisms of Drug Resistance in Fungi and Their Significance in Biofilms - Antibiofilm Agents: From Diagnosis to Treatment and Prevention - page 59

Epsztejn S, Glickstein H, Picard V, Slotki IN, Breuer W, Beaumont C, Cabantchik ZI (1999)
H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress response and
induces multidrug resistance properties. Blood 94:3593-3603
Fanning S, Mitchell AP (2012) Fungal biofilms. PLoS Pathog 8:e1002585
Favre B, Didmon M, Ryder NS (1999) Multiple amino acid substitutions in lanosterol 14alpha-
demethylase contribute to azole resistance in Candida albicans . Microbiology 145:2715-2725
Finkel JS, Xu W, Huang D, Hill EM, Desai JV, Woolford CA, Nett JE, Taff H, Norice CT, Andes
DR, Lanni F, Mitchell AP (2012) Portrait of Candida albicans adherence regulators. PLoS
Pathog 8:e1002525
Flowers SA, Barker KS, Berkow EL, Toner G, Chadwick SG, Gygax SE et al (2012) Gain-of-
function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant
clinical isolates of Candida albicans . Eukaryot Cell 11:1289-1299
Fratti RA, Belanger PH, Ghannoum MA, Edwards JE Jr, Filler SG (1998) Endothelial cell injury
caused by Candida albicans is dependent on iron. Infect Immun 66:191-196
Fridkin SK (2005) The changing face of fungal infections in health care settings. Clin Infect Dis
41:1455-1460
Gaur M, Choudhury D, Prasad R (2005) Complete inventory of ABC proteins in human patho-
genic yeast, Candida albicans . J Mol Microbiol Biotechnol 9:3-15
Gaur M, Puri N, Manoharlal R, Rai V, Mukhopadhayay G, Choudhury D et al (2008) MFS
transportome of the human pathogenic yeast Candida albicans . BMC Genomics 9:579
Ge SH, Wan Z, Li J, Xu J, Li RY, Bai FY (2010) Correlation between azole susceptibilities,
genotypes, and ERG11 mutations in Candida albicans isolates associated with vulvovaginal
candidiasis in China. Antimicrob Agents Chemother 54:3126-3131
GhannoumMA, Rice LB (1999) Antifungal agents: mode of action, mechanisms of resistance, and
correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 12:501-517
Gow NA, van de Veerdonk FL, Brown AJ, Netea MG (2011) Candida albicans morphogenesis
and host defence: discriminating invasion from colonization. Nat Rev Microbiol 10:112-122
Hameed S, Dhamgaye S, Singh A, Goswami SK, Prasad R (2011) Calcineurin signaling and
membrane lipid homeostasis regulates iron mediated multidrug resistance mechanisms in
Candida albicans . PLoS ONE 6(4):e18684
Hawser SP, Douglas LJ (1994) Biofilm formation by Candida species on the surface of catheter
materials in vitro. Infect Immun 62(3):915-921
Heilmann CJ, Schneider S, Barker KS, Rogers PD, Morschh¨user J (2010) An A643T mutation in
the transcription factor Upc2p causes constitutive ERG11 upregulation and increased flucon-
azole resistance in Candida albicans . Antimicrob Agents Chemother 54:353-359
Heitman J (2011) Microbial pathogens in the fungal kingdom. Fungal Biol Rev 25:48-60
Henry KW, Nickels JT, Edlind TD (2000) Upregulation of ERG genes in Candida species by
azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother 44:2693-2700
Heymann P, Gerads M, Schaller M, Dromer F, Winkelmann G, Ernst JF (2002) The siderophore
iron transporter of Candida albicans (Sit1p/Arn1p) mediates uptake of ferrichrome-type
siderophores and is required for epithelial invasion. Infect Immun 70:5246-5255
Hoot SJ, Smith AR, Brown RP, White TC (2011) An A643V amino acid substitution in Upc2p
contributes to azole resistance in well-characterized clinical isolates of Candida albicans .
Antimicrob Agents Chemother 55:940-942
Karababa M, Coste AT, Rognon B, Bille J, Sanglard D (2004) Comparison of gene expression
profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to
drugs inducing multidrug transporters. Antimicrob Agents Chemother 48:3064-3079
Katiyar SK, Edlind TD (2001) Identification and expression of multidrug resistance related ABC
transporter genes in Candida krusei . Med Mycol 39:109-116
Kohli A, Smirti, Mukhopadhyay K, Rattan A, Prasad R (2002) In vitro low-level resistance to
azole in Candida albicans is associated with changes in membrane fluidity and asymmetry.
Antimicrob Agents Chemother 46:1046-1052